ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,605Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 2094

$687K Total Retail Price of All Prescriptions

Rank: 261 out of 2094

387 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,351 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
DONEPEZIL HCL 436 436 1 20
SIMVASTATIN 419 415 2 1
FUROSEMIDE 359 359 3 6
LEVOTHYROXINE SODIUM 347 337 4 3
OMEPRAZOLE 305 301 5 4
NAMENDA 286 286 6 32
AMLODIPINE BESYLATE 256 256 7 2
QUETIAPINE FUMARATE 210 209 8 71
SERTRALINE HCL 206 201 9 26
LISINOPRIL 200 200 10 7
WARFARIN SODIUM 194 145 11 11
METOPROLOL TARTRATE 185 185 12 10
MIRTAZAPINE 177 177 13 43
DIOVAN 169 161 14 13
METOPROLOL SUCCINATE 163 160 15 9
ENALAPRIL MALEATE 147 147 16 25
ATORVASTATIN CALCIUM 147 146 16 5
LOSARTAN POTASSIUM 143 141 18 17
CITALOPRAM HBR 124 112 19 47
FELODIPINE ER 124 117 19 259
RISPERIDONE 123 123 21 56
ATENOLOL 121 121 22 21
SANTYL 117 117 23 114
CARBIDOPA-LEVODOPA 109 109 24 102
CLOPIDOGREL 101 98 25 22
ESCITALOPRAM OXALATE 99 99 26 46
LEVOFLOXACIN 96 94 27 70
CYMBALTA 89 89 28 61
OXYCODONE-ACETAMINOPHEN 86 85 S2 29 40
BENICAR 86 86 29 108
DIVALPROEX SODIUM 86 86 29 69
GABAPENTIN 86 86 29 23
ALENDRONATE SODIUM 85 80 33 30
PREDNISONE 83 83 34 54
ZOLPIDEM TARTRATE 75 75 35 14
SINGULAIR 73 71 36 64
FLUTICASONE PROPIONATE 72 72 37 41
FAMOTIDINE 71 71 38 34
ADVAIR DISKUS 71 68 38 36
ISOSORBIDE MONONITRATE ER 71 71 38 57
HYDROCHLOROTHIAZIDE 71 71 38 12
ALLOPURINOL 60 60 42 50
SEROQUEL 59 59 43 172
HEPARIN SODIUM 59 59 43 244
CARVEDILOL 59 59 43 19
VENLAFAXINE HCL ER 57 57 46 183
PLAVIX 56 56 47 38
POTASSIUM CHLORIDE 55 55 48 24
METFORMIN HCL 55 43 48 8
KETOCONAZOLE 55 55 48 196
IBUPROFEN 54 53 51 73
PHENYTOIN SODIUM EXTENDED 54 54 51 158
POLYETHYLENE GLYCOL 3350 53 53 53 75
OXYBUTYNIN CHLORIDE ER 51 47 54 138
NEXIUM 51 51 54 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.